HighTower Advisors, LLC - VISTAGEN THERAPEUTICS INC ownership

VISTAGEN THERAPEUTICS INC's ticker is VTGN and the CUSIP is 92840H202. A total of 53 filers reported holding VISTAGEN THERAPEUTICS INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.3%.

Quarter-by-quarter ownership
HighTower Advisors, LLC ownership history of VISTAGEN THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$15,000
+25.0%
121,2730.0%0.00%
Q4 2022$12,000
-47.8%
121,273
-22.9%
0.00%
Q3 2022$23,000
-83.8%
157,273
-3.0%
0.00%
Q2 2022$142,000
-29.0%
162,0780.0%0.00%
Q1 2022$200,000
-24.8%
162,078
+19.1%
0.00%
-100.0%
Q4 2021$266,000
-28.5%
136,0780.0%0.00%0.0%
Q3 2021$372,000
-13.3%
136,0780.0%0.00%0.0%
Q2 2021$429,000
+59.5%
136,078
+7.9%
0.00%0.0%
Q1 2021$269,000
+192.4%
126,078
-4.7%
0.00%
Q3 2020$92,000
+31.4%
132,3280.0%0.00%
Q2 2020$70,000
+20.7%
132,3280.0%0.00%
Q1 2020$58,000
-36.3%
132,3280.0%0.00%
-100.0%
Q4 2019$91,000
-35.9%
132,3280.0%0.00%0.0%
Q3 2019$142,000
+47.9%
132,328
-0.0%
0.00%0.0%
Q2 2019$96,000
+146.2%
132,353
+326.3%
0.00%
Q1 2019$39,000
-15.2%
31,045
-0.8%
0.00%
Q4 2018$46,000
+35.3%
31,295
+31.9%
0.00%
Q3 2018$34,000
+6.2%
23,7260.0%0.00%
Q2 2018$32,000
+68.4%
23,726
+12.2%
0.00%
Q1 2018$19,000
-13.6%
21,149
+4.6%
0.00%
Q4 2017$22,000
-31.2%
20,2150.0%0.00%
Q3 2017$32,000
-15.8%
20,2150.0%0.00%
Q2 2017$38,000
-2.6%
20,2150.0%0.00%
Q1 2017$39,000
-48.0%
20,2150.0%0.00%
-100.0%
Q4 2016$75,000
-12.8%
20,2150.0%0.00%0.0%
Q3 2016$86,000
+8.9%
20,2150.0%0.00%0.0%
Q2 2016$79,00020,2150.00%
Other shareholders
VISTAGEN THERAPEUTICS INC shareholders Q4 2020
NameSharesValueWeighting ↓
ACUTA CAPITAL PARTNERS, LLC 11,728,033$36,943,00014.76%
VR Adviser, LLC 16,047,286$50,549,0006.13%
COMMODORE CAPITAL LP 3,331,315$10,494,0003.66%
Ghost Tree Capital, LLC 2,000,000$6,300,0001.73%
EPIQ PARTNERS, LLC 932,956$2,939,0001.47%
SPHERA FUNDS MANAGEMENT LTD. 4,080,673$12,854,0000.87%
SILVERARC CAPITAL MANAGEMENT, LLC 615,547$1,939,0000.86%
HighVista Strategies LLC 308,096$971,0000.69%
NEA Management Company, LLC 16,302,596$51,353,0000.67%
Nicholas Investment Partners, LP 2,753,880$8,675,0000.54%
View complete list of VISTAGEN THERAPEUTICS INC shareholders